Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Barrett

Showing results (11-20 of 349) with videos related to

Pageof 35
Sort By:
Cytotherapy|April 4, 2017
Cytotherapy and ISCT -The Synergy between a journal and its societyJohn Barrett
British Journal of Haematology|August 23, 2019
Photodepletion - shedding light on allograft reactionsJohn Barrett
Best Practice & Research. Clinical Haematology|November 24, 2018
Why is a 3-year NRM following allogeneic transplantation still stuck at approximately 20%?John Barrett
Current Opinion in Immunology|July 29, 2006
Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environmentJohn Barrett
Cytotherapy|November 3, 2018
Cytotherapy in the 21<sup>st</sup> CenturyJohn Barrett
Cytotherapy|August 27, 2002
Allogeneic marrow transplantation--dinosaur or bird?John Barrett
British Journal of Haematology|September 19, 2022
Screening for mercaptopurine intolerance in ALL - target the genes or their product?John Barrett
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2018
T Cell Tumor Immunotherapy: Oncolysis Beats LymphodepletionJohn Barrett
Blood|August 6, 2011
CMV: when bad viruses turn goodA John Barrett
Journal of Leukocyte Biology|February 5, 2015
A new checkpoint in the path to GVHD? How bedside-to-bench stem cell transplant studies can inform human GVHD biologyAustin John Barrett
Pageof 35

Showing results (11-20 of 349) with videos related to

Sort By:
Pageof 35
Cytotherapy|April 4, 2017
Cytotherapy and ISCT -The Synergy between a journal and its societyJohn Barrett
British Journal of Haematology|August 23, 2019
Photodepletion - shedding light on allograft reactionsJohn Barrett
Best Practice & Research. Clinical Haematology|November 24, 2018
Why is a 3-year NRM following allogeneic transplantation still stuck at approximately 20%?John Barrett
Current Opinion in Immunology|July 29, 2006
Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environmentJohn Barrett
Cytotherapy|November 3, 2018
Cytotherapy in the 21<sup>st</sup> CenturyJohn Barrett
Cytotherapy|August 27, 2002
Allogeneic marrow transplantation--dinosaur or bird?John Barrett
British Journal of Haematology|September 19, 2022
Screening for mercaptopurine intolerance in ALL - target the genes or their product?John Barrett
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2018
T Cell Tumor Immunotherapy: Oncolysis Beats LymphodepletionJohn Barrett
Blood|August 6, 2011
CMV: when bad viruses turn goodA John Barrett
Journal of Leukocyte Biology|February 5, 2015
A new checkpoint in the path to GVHD? How bedside-to-bench stem cell transplant studies can inform human GVHD biologyAustin John Barrett
Pageof 35